Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Defensin beta 122 (DEFB122) is a member of the beta-defensin family, a group of small, cationic, disulfide-rich antimicrobial peptides vital to innate immunity and primarily expressed in epithelial and reproductive tissues[1][3][5]. DEFB122 is located within the human beta-defensin cluster on chromosome 20q11.1, which comprises several genes predominantly expressed in the male reproductive tract and implicated in both antimicrobial defense and reproductive function[1][3][5]. However, human DEFB122 is reported as a pseudogene (DEFB122P), meaning the gene is not believed to encode a functional protein due to a disruption in the coding sequence which leads to truncation and loss of the conserved defensin structure[1]. Thus, while functional orthologs exist in macaques, the human DEFB122 gene does not produce a functional protein and is not considered an active therapeutic or diagnostic target[1]. The human DEFB122 gene is a pseudogene and, as such, does not produce a functional peptide with the canonical defensin fold due to a shifted splice site and premature stop codon[1]. Beta-defensins in general play roles in host defense, particularly antimicrobial activity against bacteria, viruses, and fungi, as well as involvement in fertility and sperm function, but these roles pertain to other members of the family and not to human DEFB122 itself[1][2][3][5].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Defensin beta 122 (DEFB122).